当前位置：
X-MOL 学术
›
Liver Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Improved Tumor Response to Lenvatinib Re-Treatment after Failure of Immune Checkpoint Inhibitors in a Patient with Advanced Hepatocellular Carcinoma
Liver Cancer ( IF 11.6 ) Pub Date : 2021-06-16 , DOI: 10.1159/000516692 Satoru Hagiwara 1 , Naoshi Nishida 1 , Masatoshi Kudo 1
Liver Cancer
中文翻译：
在晚期肝细胞癌患者中免疫检查点抑制剂失败后对乐伐替尼再治疗的改善的肿瘤反应
肝癌
更新日期：2021-06-17
Liver Cancer ( IF 11.6 ) Pub Date : 2021-06-16 , DOI: 10.1159/000516692 Satoru Hagiwara 1 , Naoshi Nishida 1 , Masatoshi Kudo 1
Affiliation
Liver Cancer
中文翻译：
在晚期肝细胞癌患者中免疫检查点抑制剂失败后对乐伐替尼再治疗的改善的肿瘤反应
肝癌
京公网安备 11010802027423号